McKesson Corporation Sample Clauses
POPULAR SAMPLE Copied 1 times
McKesson Corporation. This certifies that , or registered assigns, is the registered owner of the number of Rights set forth above, each of which entitles the owner thereof, subject to the terms, provisions and conditions of the Rights Agreement, dated as of October 22, 2004 (the “Rights Agreement”), between McKesson Corporation, a Delaware corporation (the “Company”), and The Bank of New York, a [New York corporation] (the “Rights Agent”), to purchase from the Company at any time prior to 5:00 P.M. (Eastern time) on October 22, 2014 (unless such date is extended prior thereto by the Board of Directors) at the office or offices of the Rights Agent designated for such purpose, or its successors as Rights Agent, one one-hundredth (1/100) of a fully paid, non-assessable share of Series A Junior Participating Preferred Stock (the “Preferred Stock”) of the Company, at a purchase price of $100 per one one-hundredth (1/100) of a share (the “Purchase Price”), upon presentation and surrender of this Rights Certificate with the Form of Election to Purchase and related Certificate duly executed. The number of Rights evidenced by this Rights Certificate (and the number of shares which may be purchased upon exercise thereof) set forth above, and the Purchase Price per share set forth above, are the number and Purchase Price as of October 22, 2004, based on the Preferred Stock as constituted at such date. The Company reserves the right to require prior to the occurrence of a Triggering Event (as such term is defined in the Rights Agreement) that a number of Rights be exercised so that only whole shares of Preferred Stock will be issued. Upon the occurrence of a Section 11(a)(ii) Event (as such term is defined in the Rights Agreement), if the Rights evidenced by this Rights Certificate are beneficially owned by (i) an Acquiring Person, an Adverse Person or an Affiliate or Associate of any such Acquiring Person or Adverse Person (as such terms are defined in the Rights Agreement), (ii) a transferee of any such Acquiring Person, Adverse Person, Associate or Affiliate, or (iii) under certain circumstances specified in the Rights Agreement, a transferee of a person who, after such transfer, became an Acquiring Person, an Adverse Person, or an Affiliate or Associate of an Acquiring Person or Adverse Person, such Rights shall become null and void and no holder hereof shall have any right with respect to such Rights from and after the occurrence of such Section 11(a)(ii) Event. As provided in the Ri...
McKesson Corporation. McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and healthcare information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson is the longest-operating company in healthcare today, marking its 175th anniversary last year. Over the course of its history, McKesson has grown by providing pharmaceutical and medical- surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payers; hospital and retail pharmacy automation; and services for manufacturers and payers designed to improve outcomes for patients. For more information about McKesson, visit ▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇; for more information about RAC services, visit InterQual for Hospitals . 3M is a registered trademark of 3M Company.
McKesson Corporation. ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇
McKesson Corporation. Second security interest in all of the assets of Accentia, including all subsidiary stock owned by Accentia (1) Southwest Bank f/k/a Missouri State Bank – Third security interest in all of the assets of Accentia, including all subsidiary stock owned by Accentia(1)
(1) The Laurus, McKesson and MSB interests in 18,000,000 shares of Biovest International, Inc. (BVTI) to be pledged to Purchasers will be released from the foregoing pledge and security agreements at Closing
McKesson Corporation. Type of Contract: Buying Terms Regarding Distribution of Product Products: Medi-Jector Vision® (MJ7) Term of Contract: *** Field & Territory: For the insulin diabetes market in the U.S. ***-Denotes portions omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934. A copy of this agreement with the omitted information intact has been filed separately with the Securities and Exchange Commission.
McKesson Corporation. By: -------------------------------------------
McKesson Corporation. Second security interest in all of the assets of Accentia, including all subsidiary stock owned by Accentia (1)
(c) Southwest Bank f/k/a Missouri State Bank – Third security interest in all of the assets of Accentia, including all subsidiary stock owned by Accentia (1)
(1) The Laurus, McKesson and MSB interests in 18,000,000 shares of Biovest International, Inc. (BVTI) to be pledged to Purchasers will be released from the foregoing pledge and security agreements at Closing
(d) Laurus Master Fund – First security interest in all of the assets of Biovest and all of its assets in its subsidiaries including BiovaxID, Inc.
(e) Laurus Master Fund – First security interest in all of the assets of Biolender, LLC
(f) Laurus Master Fund – First security interest in all of the assets of TEAMM
(g) Laurus Master Fund – First security interest in all of the assets of Analytica (U.S. only)
McKesson Corporation. By: /s/ Marc. ▇. ▇▇▇▇ ------------------------------------- Name: ▇▇▇▇ ▇. ▇▇▇▇ Title: Executive Vice President Corporate Strategy and Business Development SPIRIT ACQUISITION CORPORATION By: /s/ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ------------------------------------- Name: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ Title: Vice President and Secretary D&K HEALTHCARE RESOURCES, INC. By: /s/ ▇. ▇▇▇▇ ▇▇▇▇▇▇▇▇▇, III ------------------------------------- Name: ▇. ▇▇▇▇ ▇▇▇▇▇▇▇▇▇, III Title: Chairman and Chief Executive Officer ANNEX A CONDITIONS TO THE OFFER Notwithstanding any other provision of the Offer, Purchaser shall not be required to accept for payment any Shares tendered pursuant to the Offer, and may extend, terminate or amend the Offer, if (i) immediately prior to the expiration of the Offer, the Minimum Condition shall not have been satisfied, (ii) any applicable waiting period under the HSR Act shall not have expired or been terminated prior to the expiration of the Offer, or (iii) at any time on or after the date of this Agreement and prior to the expiration of the Offer, any of the following conditions shall exist:
McKesson Corporation. Core Distribution Agreement